SEC Form 3 · accession 0001213900-15-000387
RELMADA THERAPEUTICS, INC. · RLMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nabil Yazgi
Director
Period of report
Jan 6, 2015
Accepted (ET)
Jan 16, 2015 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001553643
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 125,000 | D | ||
| Common Stock | holding | — | — | — | 60,000 | I | Nabil Yazgi PA Cash Balance Plan & Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $1.50 | holding | — | — | — | — | Feb 26, 2024 | Common Stock | 48,662 | — | D |
| Warrants | $2.25 | holding | — | — | — | Jun 10, 2014 | Jun 10, 2019 | Common Stock | 15,000 | — | I |
| Warrants | $0.80 | holding | — | — | — | Jul 31, 2012 | Jul 31, 2019 | Common Stock | 31,250 | — | D |
Explanation of responses
- F1The options were granted on February 26, 2014 (the "Grant Date"). The stock options vest on the Grant Date based on the following vesting schedule: Twenty-five percent (25%) of the stock options of the initial grant shall vest on the first anniversary of the Grant Date and the remaining seventy-five percent (75%) shall vest in equal quarterly increments of 6.25% of the option grant over the following three (3) year period.